Edwards Lifesciences | EW - 股票



金融业
股票价格
USD
资产
USD 13.32B
现金及等价物
USD 2.4B
销售成本
USD 362.6M
流动资产
USD 6.23B
流动负债
USD 1.41B
债务
USD 600M
EBIT
USD 514.7M
EBITDA
USD 70.1M
员工
15.8K
EPS每股收益
USD 0.78
股本和储备
USD 10.33B
销售毛利
USD 1.29B
债务利息支出
USD 35.9M
利息收入
USD 56.3M
贷款资金
USD 600M
市值
USD 50.59B
净收入
USD 380.7M
营业费用
USD 1.13B
营业利润
USD 514.7M
普通股股本
USD 580.7M
PE价格收益
26.87
税前利润
USD 348.4M
销售收入
USD 1.65B
销售和管理费用
USD 522.2M
股票
USD 1.12B
贸易债权人
USD 181.1M
应收帐款人
USD 912.1M


股票 更改 日
Abbott USD 6.99B 501M 2026-03
Artivion USD 97.99M 5.57M 2026-03
AtriCure USD 81.14M 2.65M 2026-03
Baxter International USD 2.32B 84M 2026-03
Becton, Dickinson and Co. USD 3.36B 728M 2026-03
Boston Scientific USD 3.12B 174M 2026-03
Cooper Companies USD 846M 35M 2025-09
Dexcom USD 693.6M 64.5M 2026-03
Edwards Lifesciences USD 1.12B 7.2M 2026-03
Globus Medical USD 772.6M 13.32M 2026-03
ICU Medical USD 605.59M 10.27M 2026-03
Inogen USD 25.08M 762K 2025-09
Insulet USD 462.5M 9.9M 2026-03
Integra LifeSciences USD 495.04M 2.3M 2026-03
Intuitive Surgical USD 1.95B 105.1M 2026-03
J&J USD 14.58B 392M 2026-03
Masimo USD 400M 61.4M 2026-03
Medtronic USD 6.31B 153M 2025-12
Merit Medical Systems USD 352.39M 18.68M 2026-03
Stryker USD 5.42B 109M 2026-03
Tandem Diabetes Care USD 126.4M 2.37M 2026-03
Teleflex USD 380.86M 23.53M 2026-03
Zimmer Biomet Holdings USD 2.25B 39.6M 2026-03